vs
EAGLE MATERIALS INC（EXP）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
EAGLE MATERIALS INC的季度营收约是ICU MEDICAL INC的1.0倍（$556.0M vs $540.7M），EAGLE MATERIALS INC净利率更高（18.5% vs -2.9%，领先21.4%），EAGLE MATERIALS INC同比增速更快（-0.4% vs -14.1%），EAGLE MATERIALS INC自由现金流更多（$60.8M vs $36.0M），过去两年EAGLE MATERIALS INC的营收复合增速更高（8.0% vs -2.3%）
Eagle Materials Inc.是总部位于美国得克萨斯州达拉斯的建筑材料生产企业，主营产品包括水泥、混凝土、建筑骨料、石膏、墙板、纸板以及水力压裂作业专用砂，产品广泛应用于建筑施工、能源开发等多个领域。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
EXP vs ICUI — 直观对比
营收规模更大
EXP
是对方的1.0倍
$540.7M
营收增速更快
EXP
高出13.8%
-14.1%
净利率更高
EXP
高出21.4%
-2.9%
自由现金流更多
EXP
多$24.8M
$36.0M
两年增速更快
EXP
近两年复合增速
-2.3%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $556.0M | $540.7M |
| 净利润 | $102.9M | $-15.7M |
| 毛利率 | 28.9% | 37.5% |
| 营业利润率 | — | 1.0% |
| 净利率 | 18.5% | -2.9% |
| 营收同比 | -0.4% | -14.1% |
| 净利润同比 | -13.9% | 34.0% |
| 每股收益（稀释后） | $3.22 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXPICUI
| Q4 25 | $556.0M | $540.7M | ||
| Q3 25 | $638.9M | $537.0M | ||
| Q2 25 | $634.7M | $548.9M | ||
| Q1 25 | $470.2M | $604.7M | ||
| Q4 24 | $558.0M | $629.8M | ||
| Q3 24 | $623.6M | $589.1M | ||
| Q2 24 | $608.7M | $596.5M | ||
| Q1 24 | $476.7M | $566.7M |
净利润EXPICUI
| Q4 25 | $102.9M | $-15.7M | ||
| Q3 25 | $137.4M | $-3.4M | ||
| Q2 25 | $123.4M | $35.3M | ||
| Q1 25 | $66.5M | $-15.5M | ||
| Q4 24 | $119.6M | $-23.8M | ||
| Q3 24 | $143.5M | $-33.0M | ||
| Q2 24 | $133.8M | $-21.4M | ||
| Q1 24 | $77.1M | $-39.5M |
毛利率EXPICUI
| Q4 25 | 28.9% | 37.5% | ||
| Q3 25 | 31.3% | 37.4% | ||
| Q2 25 | 29.2% | 37.9% | ||
| Q1 25 | 22.2% | 34.7% | ||
| Q4 24 | 31.9% | 36.1% | ||
| Q3 24 | 32.7% | 34.8% | ||
| Q2 24 | 30.7% | 34.8% | ||
| Q1 24 | 25.1% | 32.7% |
营业利润率EXPICUI
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | 32.8% | 6.0% | ||
| Q3 24 | 34.2% | 1.4% | ||
| Q2 24 | 32.0% | 1.3% | ||
| Q1 24 | 26.9% | -1.9% |
净利率EXPICUI
| Q4 25 | 18.5% | -2.9% | ||
| Q3 25 | 21.5% | -0.6% | ||
| Q2 25 | 19.4% | 6.4% | ||
| Q1 25 | 14.1% | -2.6% | ||
| Q4 24 | 21.4% | -3.8% | ||
| Q3 24 | 23.0% | -5.6% | ||
| Q2 24 | 22.0% | -3.6% | ||
| Q1 24 | 16.2% | -7.0% |
每股收益（稀释后）EXPICUI
| Q4 25 | $3.22 | $-0.63 | ||
| Q3 25 | $4.23 | $-0.14 | ||
| Q2 25 | $3.76 | $1.43 | ||
| Q1 25 | $2.01 | $-0.63 | ||
| Q4 24 | $3.56 | $-0.97 | ||
| Q3 24 | $4.26 | $-1.35 | ||
| Q2 24 | $3.94 | $-0.88 | ||
| Q1 24 | $2.23 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $419.0M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.5B | $2.1B |
| 总资产 | $3.8B | $4.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EXPICUI
| Q4 25 | $419.0M | — | ||
| Q3 25 | $35.0M | — | ||
| Q2 25 | $59.7M | — | ||
| Q1 25 | $20.4M | — | ||
| Q4 24 | $31.2M | $308.6M | ||
| Q3 24 | $93.9M | $312.5M | ||
| Q2 24 | $46.5M | $302.6M | ||
| Q1 24 | $34.9M | $251.4M |
总债务EXPICUI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $1.1B | — |
股东权益EXPICUI
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.5B | $2.1B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.5B | $2.0B | ||
| Q3 24 | $1.4B | $2.0B | ||
| Q2 24 | $1.4B | $2.0B | ||
| Q1 24 | $1.3B | $2.1B |
总资产EXPICUI
| Q4 25 | $3.8B | $4.1B | ||
| Q3 25 | $3.4B | $4.1B | ||
| Q2 25 | $3.4B | $4.1B | ||
| Q1 25 | $3.3B | $4.2B | ||
| Q4 24 | $3.0B | $4.2B | ||
| Q3 24 | $3.1B | $4.3B | ||
| Q2 24 | $3.0B | $4.3B | ||
| Q1 24 | $2.9B | $4.3B |
负债/权益比EXPICUI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.84× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $170.8M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | $60.8M | $36.0M |
| 自由现金流率自由现金流/营收 | 10.9% | 6.6% |
| 资本支出强度资本支出/营收 | 19.8% | 4.6% |
| 现金转化率经营现金流/净利润 | 1.66× | — |
| 过去12个月自由现金流最近4个季度 | $231.8M | $91.8M |
8季度趋势，按日历期对齐
经营现金流EXPICUI
| Q4 25 | $170.8M | $60.6M | ||
| Q3 25 | $204.6M | $56.7M | ||
| Q2 25 | $136.6M | $11.2M | ||
| Q1 25 | $62.8M | $51.3M | ||
| Q4 24 | $119.9M | $40.2M | ||
| Q3 24 | $233.3M | $36.1M | ||
| Q2 24 | $132.6M | $82.0M | ||
| Q1 24 | $63.4M | $45.8M |
自由现金流EXPICUI
| Q4 25 | $60.8M | $36.0M | ||
| Q3 25 | $96.1M | $27.6M | ||
| Q2 25 | $60.5M | $-8.5M | ||
| Q1 25 | $14.5M | $36.7M | ||
| Q4 24 | $72.5M | $16.1M | ||
| Q3 24 | $166.8M | $16.2M | ||
| Q2 24 | $99.5M | $62.5M | ||
| Q1 24 | $30.9M | $29.9M |
自由现金流率EXPICUI
| Q4 25 | 10.9% | 6.6% | ||
| Q3 25 | 15.0% | 5.1% | ||
| Q2 25 | 9.5% | -1.5% | ||
| Q1 25 | 3.1% | 6.1% | ||
| Q4 24 | 13.0% | 2.6% | ||
| Q3 24 | 26.7% | 2.7% | ||
| Q2 24 | 16.3% | 10.5% | ||
| Q1 24 | 6.5% | 5.3% |
资本支出强度EXPICUI
| Q4 25 | 19.8% | 4.6% | ||
| Q3 25 | 17.0% | 5.4% | ||
| Q2 25 | 12.0% | 3.6% | ||
| Q1 25 | 10.3% | 2.4% | ||
| Q4 24 | 8.5% | 3.8% | ||
| Q3 24 | 10.7% | 3.4% | ||
| Q2 24 | 5.4% | 3.3% | ||
| Q1 24 | 6.8% | 2.8% |
现金转化率EXPICUI
| Q4 25 | 1.66× | — | ||
| Q3 25 | 1.49× | — | ||
| Q2 25 | 1.11× | 0.32× | ||
| Q1 25 | 0.94× | — | ||
| Q4 24 | 1.00× | — | ||
| Q3 24 | 1.63× | — | ||
| Q2 24 | 0.99× | — | ||
| Q1 24 | 0.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXP
| External Customers | $283.5M | 51% |
| Gypsum Wallboard | $175.9M | 32% |
| Recycled Paperboard | $47.8M | 9% |
| Corporate Joint Venture | $29.4M | 5% |
| Other | $11.8M | 2% |
| Western Pennsylvania Acquisition | $7.6M | 1% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
